Amgen Earnings, Revenue beat in Q4 By Investing.com

Amgen (NASDAQ:AMGN) reported on Tuesday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Amgen announced earnings per share of $3.81 on revenue of $6.63B. Analysts polled by Investing.com anticipated EPS of $3.39 on revenue of $6.58B.

Amgen shares are up 3% from the beginning of the year and are trading at $234.00 , down-from-52-week-high.They are outperforming the S&P 500 which is up 1.83% from the start of the year.

Amgen shares lost 2.59% in after-hours trade the report.

Amgen follows other major Healthcare sector earnings this month

Amgen’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar